Claris
Menu
About Us
Company Overview
Milestones
Investors
Financials
Corporate Governance
Board of Directors' Profile
Shareholding Pattern
Notices/ Results
Registrar & Transfer Agent
Investor Contact
Unclaimed Dividend
Policies and Codes
Letter of appointment to Independent Directors
Media
Press Room
Media Contact
Media Gallery
Career
Overview
Culture
Current Openings
Apply
Contact Us
Policies and Codes
Nomination and Remuneration Policy
Corporate Social Responsibility Policy
Familiarization Programme - Independent Directors
2015-16
2016-17
Archive
What’s New?
Claris completes sale of its Global Generic Injectables Business to Baxter
Financials
Notices/ Results
Annual Report 2016-17